Intrathecal Nalbuphine Versus Midazolam in Cesarean Section

• Status: Completed
• Trial end date: 2019-12-01
• Target enrollment: 0
• Participant gender: Female

Summary

Adequate pain management is important to facilitate the functional recovery and enable the patients for rapid rehabilitation of normal activity .

Various adjuvants were being used with intrathecal bupivacain to prolong & improve postoperative pain relief in patients undergoing cesarean section .

The aim of this study was to compare intrathecal nalbuphine versus intrathecal midazolam in patient undergoing cesarean section. The investigators primary aims were to compare the characteristics of sensory and motor block, the effective analgesic time, and analgesic requirement. Secondary aims were to compare the side effects, sedation score and apgare score.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Zagazig University
• Treatments: Bupivacaine; Midazolam; Nalbuphine

Criteria

Inclusion Criteria: -

• Female gender .

• Age : 18 - 40 years old .

• Physical status : ASA II .

• Elective cesarean section

Exclusion Criteria:

• - Patient refusal .

• History of hypertension or cardiac diseases .

• Psychiatric disorders .

• Coagulopathy .

• Allergy to study drugs .

• Contraindication to spinal anesthesia .

• Failure of spinal anesthesia .